Windward Capital Management Co. CA Lowers Holdings in CME Group Inc. $CME

Windward Capital Management Co. CA lowered its position in shares of CME Group Inc. (NASDAQ:CME) by 3.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,827 shares of the financial services provider’s stock after selling 3,265 shares during the period. CME Group comprises approximately 1.8% of Windward Capital Management Co. CA’s holdings, making the stock its 17th largest holding. Windward Capital Management Co. CA’s holdings in CME Group were worth $22,891,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Sage Private Wealth Group LLC raised its holdings in shares of CME Group by 1.8% in the 4th quarter. Sage Private Wealth Group LLC now owns 3,439 shares of the financial services provider’s stock valued at $939,000 after purchasing an additional 62 shares in the last quarter. Turtle Creek Wealth Advisors LLC increased its holdings in CME Group by 15.7% during the fourth quarter. Turtle Creek Wealth Advisors LLC now owns 24,202 shares of the financial services provider’s stock valued at $6,609,000 after buying an additional 3,279 shares during the period. B. Metzler seel. Sohn & Co. AG raised its stake in CME Group by 4.4% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 28,546 shares of the financial services provider’s stock worth $7,795,000 after buying an additional 1,192 shares in the last quarter. West Michigan Advisors LLC raised its stake in CME Group by 5.7% in the fourth quarter. West Michigan Advisors LLC now owns 8,286 shares of the financial services provider’s stock worth $2,263,000 after buying an additional 446 shares in the last quarter. Finally, HB Wealth Management LLC lifted its holdings in CME Group by 7.8% during the fourth quarter. HB Wealth Management LLC now owns 9,753 shares of the financial services provider’s stock worth $2,663,000 after buying an additional 708 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 0.1%

CME stock opened at $285.47 on Friday. The company has a market capitalization of $102.38 billion, a P/E ratio of 24.36, a price-to-earnings-growth ratio of 2.91 and a beta of 0.26. CME Group Inc. has a 12 month low of $257.17 and a 12 month high of $329.16. The firm’s fifty day simple moving average is $304.87 and its 200-day simple moving average is $285.91. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.03.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter last year, the company posted $2.80 earnings per share. The firm’s revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group Inc. will post 12.37 earnings per share for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were issued a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend was Tuesday, March 10th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. CME Group’s payout ratio is presently 46.59%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes — CME reported record first-quarter revenue and a substantial rise in average daily volume, driven by heavier client activity and demand for hedging. This underpins growth momentum for transaction-driven clearing and data businesses. CME Group Posts Record Q1 Revenue As Trading Volumes Surge
• Positive Sentiment: Record daily activity and increased hedging demand — management highlighted record daily trading activity and said rising market risk has boosted demand for hedge trades, supporting fee and clearing revenue. Increasing market risk is driving record demand for ‘hedge’ trades, CME says
• Neutral Sentiment: Earnings call/transcript and disclosures — full Q1 earnings call transcript and presentation are available for deeper review of segment trends, client mix and management commentary. Useful for investors digging into recurring vs. one‑off drivers. Full Transcript: CME Group Q1 2026 Earnings Call
• Negative Sentiment: Revenue and EPS narrowly missed some estimates — several outlets flagged that revenue and EPS were slightly below some consensus figures, which pressured the stock despite strong volumes. That “double miss” prompted near-term selling. CME Group (NASDAQ:CME) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
• Neutral Sentiment: Analysts trim targets but keep mixed ratings — TD Cowen lowered its target (keeps Buy) and Morgan Stanley trimmed its target (keeps Overweight), signaling continued confidence in the long‑term thesis despite trimming near-term upside. TD Cowen adjusts price target on CME to $323 from $340, maintains Buy
• Negative Sentiment: Goldman keeps a Sell and cuts its target — Goldman Sachs lowered its price target and retained a Sell rating, representing immediate downside vs. the prior price; that note is a clear near‑term negative catalyst. Goldman Sachs adjusts price target on CME Group to $267 from $275, maintains Sell
• Negative Sentiment: Valuation concerns — commentary from analysts and writers notes that despite strong top‑line and volume growth the stock’s valuation still looks rich to some, contributing to profit‑taking. CME Group Q1 Earnings Show Strength, But The Stock Still Looks Expensive
• Negative Sentiment: Market reaction — several outlets reported the stock slid after the print as investors digested the mix of record volumes and slight misses. CME Group (CME) Stock Slides Following Record-Breaking Q1 2026 Performance

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 5th. Piper Sandler upped their price objective on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. Raymond James Financial lifted their target price on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research note on Monday, April 6th. Barclays cut their price target on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research note on Thursday. Finally, JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a report on Thursday, April 16th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Moderate Buy” and an average target price of $306.35.

Insider Buying and Selling

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. The trade was a 31.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the transaction, the director directly owned 2,699 shares of the company’s stock, valued at $809,700. The trade was a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 8,539 shares of company stock valued at $2,713,821 in the last three months. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.